Association of chondromodulin-II Val58Ile polymorphism with radiographic joint destruction in rheumatoid arthritis

Journal of Rheumatology

Volumn 32, Issue 9, 2005, Pages 1654-1661

  Graessler, Juergen ^a,c   Verlohren, Michael ^a   Graessler, Anett ^a   Zeissig, Astrid ^a   Kuhlisch, Eberhard ^b   Kopprasch, Steffi ^a   Schroeder, Hans Egbert ^a  

^a Department of Pathological Biochemistry ^*

^b Institute of Medical Informatics and Biometry   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Candidate Gene; Chondromodulin II; Genetics; Leukocyte cell derived chemotaxin 2; Rheumatoid Arthritis

Indexed keywords

CHEMOTAXIN; CHONDROMODULIN II; DNA; EPITOPE; ISOLEUCINE; LEUKOCYTE CELL DERIVED CHEMOTAXIN 2; PROTEIN; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ARTICLE; BONE REMODELING; CARTILAGE; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; GOUT; HUMAN; INTRON; JOINT DESTRUCTION; JOINT RADIOGRAPHY; LARSEN SCORE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SCORING SYSTEM; SILENT MUTATION;

ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENOTYPE; GERMANY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOLECULAR SEQUENCE DATA; ODDS RATIO; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 24944547376     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Goldring SR. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 2002;14:406-10.
2. Haugeberg G, Orstavik RE, Kvien TK. Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol 2003;15:469-75.
3. van den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 2001;30:7-16.
4. van den Berg WB, van der Kraan PM, Scharstuhl A, van Beuningen HM. Growth factors and cartilage repair. Clin Orthop 2001:S244-50.
5. Neame PJ, Tapp H, Azizan A. Noncollagenous, nonproteoglycan macromolecules of cartilage. Cell Mol Life Sci 1999;55:1327-40.
6. Hiraki Y, Inoue H, Kondo J, et al. A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II. Purification and amino acid sequence. J Biol Chem 1996;271:22657-62.
7. Mori Y, Hiraki Y, Shukunami C, et al. Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chondromodulin-I and -II. FEBS Lett 1997;406:310-4.
8. Suzuki F. Roles of cartilage matrix proteins, chondromodulin-I and -II, in endochondral bone formation: a review. Connect Tissue Res 1996;35:303-7.
9. Yamagoe S, Akasaka T, Uchida T, et al. Expression of a neutrophil chemotactic protein LECT2 in human hepatocytes revealed by immunochemical studies using polyclonal and monoclonal antibodies to a recombinant LECT2. Biochem Biophys Res Commun 1997;237:116-20.
10. Yamagoe S, Kameoka Y, Hashimoto K, Mizuno S, Suzuki K. Molecular cloning, structural characterization, and chromosomal mapping of the human LECT2 gene. Genomics 1998;48:324-9.
11. Kameoka Y, Yamagoe S, Hatano Y, Kasama T, Suzuki K. Val58Ile polymorphism of the neutrophil chemoattractant LECT2 and rheumatoid arthritis in the Japanese population. Arthritis Rheum 2000;43:1419-20.
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Rau R, Herborn G. Development and evaluation of a modified version of the Larsen method for evaluating roentgenologic changes in chronic polyarthritis. Z Rheumatol 1997;56:127-35.
14. Cox DG, Canzian F. Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis. Bioinformatics 2001;17:738-9.
15. Falany ML, Thames AM 3rd, McDonald JM, et al. Osteoclasts secrete the chemotactic cytokine mim-1. Biochem Biophys Res Commun 2001;281:180-5.
16. Nagai H, Hamada T, Uchida T, Yamagoe S, Suzuki K. Systemic expression of a newly recognized protein, LECT2, in the human body. Pathol Int 1998;48:882-6.
17. Saito T, Okumura A, Watanabe H, et al. Increase in hepatic NKT cells in leukocyte cell-derived chemotaxin 2-deficient mice contributes to severe concanavalin A-induced hepatitis. J Immunol 2004;173:579-85.
18. Cornelis F, Faure S, Martinez M, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998;95:10746-50.
19. Cantagrel A, Navaux F, Loubet-Lescoulie P, et al. Interleukin-1 beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093-100.
20. Graudal N. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins. Scand J Rheumatol Suppl 2004;118:1-38.
21. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-83.
22. Goldring SR, Goldring MB, Buckwalter J. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop 2004;427 Suppl:S27-S36.
23. Ovejero C, Cavard C, Perianin A, et al. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology 2004;40:167-76.
24. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene 2004;341:19-39.
25. Smith E, Frenkel B. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3 beta-dependent and -independent manner. J Biol Chem 2005;280:2388-94.